SCHEMBL6546754

SCHEMBL6546754

Cc1ccc(CCCCc2ccc(C)cc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 1/20 0.64
ALOX15 P16050 1/20 0.64
CYP1A2 P05177 1/20 0.62
CYP2A6 P11509 1/20 0.62
TAAR1 Q96RJ0 1/20 0.62
HRH1 P35367 1/20 0.57
IDO1 P14902 1/20 0.52
ACHE P22303 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
HRH3 Q9Y5N1 1/20 0.48
KCNH2 Q12809 1/20 0.48
ESR1 P03372 2/20 0.46
ADRA2A P08913 2/20 0.46
ADORA3 P0DMS8 2/20 0.46
TACR2 P21452 2/20 0.46
SLC6A2 P23975 2/20 0.46
SLC6A4 P31645 2/20 0.46
SLC6A3 Q01959 2/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10571160 0.97 IGF1R (0.61) IGF1RALOX15CYP1A2CYP2A6TAAR1
SCHEMBL6546878 0.94 CYP1A2 (0.62) IGF1RALOX15CYP1A2CYP2A6TAAR1
SCHEMBL28598480 0.89 IGF1R (0.55) IGF1RALOX15CYP1A2CYP2A6TAAR1
SCHEMBL392911 0.89 ESR1 (0.61) IGF1RALOX15CYP1A2CYP2A6TAAR1
SCHEMBL6546824 0.89 MAOB (0.60) IGF1RALOX15CYP1A2CYP2A6TAAR1
SCHEMBL5610012 0.87 IGF1R (0.53) IGF1RALOX15CYP1A2CYP2A6TAAR1
SCHEMBL80498 0.87 ESR1 (0.65) IGF1RALOX15ACHEESR1ADRA2A
SCHEMBL168031 0.87 ESR1 (0.65) IGF1RALOX15ACHEESR1ADRA2A
SCHEMBL9678943 0.87 ESR1 (0.65) IGF1RALOX15ACHEESR1ADRA2A
SCHEMBL21963890 0.87 ESR1 (0.65) IGF1RALOX15ACHEESR1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12163043-B2 Curable composition comprising polysiloxane polyalkyleneglycol brush copolymers HENKEL AG & CO. KGAA (DE) 2024-12-10 US disclosed
EP-3784718-B1 PROCESS FOR THE PREPARATION OF HYDROXYL-FUNCTIONALIZED POLYETHERPOLYSILOXANE BLOCK COPOLYMERS HENKEL AG & CO KGAA (DE) 2024-06-26 EP disclosed
CN-114096590-B UV and/or thermally curable silicone-based materials and formulations 汉高股份有限及两合公司 2024-04-19 CN disclosed
EP-3663372-B1 CURABLE COMPOSITION COMPRISING POLYSILOXANE POLYALKYLENEGLYCOL BRUSH COPOLYMERS HENKEL AG & CO KGAA (DE) 2024-03-13 EP disclosed
US-20220411634-A1 SILICONE FORMULATION WITH HIGH TEMPERATURE STABILITY AND CLARITY HENKEL AG & CO. KGAA (DE) 2022-12-29 US disclosed
EP-4108726-A1 SILICONE FORMULATION WITH HIGH TEMPERATURE STABILITY AND CLARITY Henkel AG & Co. KGaA (DE) 2022-12-28 EP disclosed
US-11326027-B2 Process for the preparation of hydroxyl-functionalized polysiloxanes HENKEL AG & CO. KGAA (DE) 2022-05-10 US disclosed
CN-114096590-A UV and/or thermally curable silicone-based materials and formulations 汉高知识产权控股有限责任公司 2022-02-25 CN disclosed
EP-3953412-A1 UV AND/OR HEAT CURABLE SILICONE BASED MATERIALS AND FORMULATIONS Henkel IP & Holding GmbH (DE) 2022-02-16 EP disclosed
US-20220025180-A1 UV AND/OR HEAT CURABLE SILICONE BASED MATERIALS AND FORMULATIONS HENKEL AG & CO. KGAA (DE) 2022-01-27 US disclosed
EP-0717098-B1 A refrigerating machine oil and a fluid composition for use in a refrigerating machine NIPPON MITSUBISHI OIL CORP (JP) 2004-01-21 EP disclosed
US-5817251-A AROMATIC HYDROCARBON LUBRICANT NIPPON OIL CO., LTD. (JP) 1998-10-06 US disclosed
US-5711895-A Fluid composition for use in a refrigerating machine in which the refrigerating machine oil is at least one hydrocarbon compound of a formula consisting of two phenyl groups joined through an alkylene or alkenylene group NIPPON OIL CO., LTD. (JP) 1998-01-27 US disclosed
EP-0717098-A2 A refrigerating machine oil and a fluid composition for use in a refrigerating machine NIPPON OIL CO. LTD. (JP) 1996-06-19 EP disclosed
EP-0321174-B1 Process for preparing aminopropyl silanes TONEN CORP (JP) 1994-03-23 EP disclosed
US-4921988-A RHODIUM CATALYST, BASE, ALLYLAMINE TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) 1990-05-01 US disclosed
EP-0321174-A2 Process for preparing aminopropyl silanes Tonen Corporation (JP) 1989-06-21 EP disclosed
US-4834905-A LIQUID CRYSTAL DIELECTRICS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1989-05-30 US disclosed
US-4627933-A ESTERS, ETHERS, NITRICES, HALIDES, OR HYDROCARBONS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1986-12-09 US disclosed
EP-0104327-A2 Use of cyclic derivatives as components of liquid cristals MERCK PATENT GmbH (DE) 1984-04-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11326027-B2 Process for the preparation of hydroxyl-functionalized polysiloxanes C9, HACL2, ADH1C IGF1R 965/4885ALOX15 1048/4885CYP1A2 306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.